Hausman Diana F.'s most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 33,350 Stock Option done . Disclosure was reported to the exchange on June 12, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 33,350 | 33,350 | - | - | Stock Option | |
Zentalis Pharmaceuticals Inc | Diana F. Hausman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.62 per share. | 09 May 2024 | 3,356 | 373,876 | - | 12.6 | 42,353 | Common Stock |
Zentalis Pharmaceuticals Inc | F. Diana Hausman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 337,500 | 377,232 | - | 0 | Common Stock | |
Zentalis Pharmaceuticals Inc | Hausman Diana F. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 337,500 | 337,500 | - | - | Stock Option (Right to Buy) | |
Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 17,500 | 17,500 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 6,185 | 6,185 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 25,200 | 25,200 | - | - | Stock Option |